![SonomaEye-full-color-vector[2].png](https://static.wixstatic.com/media/bed00b_da20b9cc704044b0b048ac8ef9190470~mv2_d_3024_2195_s_2.png/v1/fill/w_177,h_123,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/SonomaEye-full-color-vector%5B2%5D.png)
Basic Science/Endpoints
Sunday, 3/24/2019
08:00 AM - 09:30 AM
Moderator: Gary D. Novack
10 minutes for each presentation and 5 minutes for discussion after each presentation
-
8:00 am - 8:15 am: Single Gene Knockout Mouse Give Clinical Clues to New Ocular Diseases (Ala Moshiri, MD, PhD)
-
8:15 am - 8:30 am: Keratoconjunctivitis Sicca in the West Highland White Terrier: A Spontaneous Canine Model of Dry Eye Disease (Sara M. Thomasy BS, DVM, PhD)
-
8:30 am - 8:45 am: Oxidative Stress-Induced Inflammatory Response Medicated by KLF4-IL17RA Signaling Axis Contributes to Age-Related Macular Degeneration (AMD) (David W. Li, PhD)
-
8:45 am - 9:00 am: Satralizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD) (Zdenka Haskova, MD, PhD)
-
9:00 am - 9:10 am: Clinical Outcome Measures for Regulatory Approval. (Gary D. Novack, PhD)
-
9:10 am – 9:15 am: Endpoints in Uveitis Clinical Trials: An Update (Rupesh Agrawal, MD)
-
9:15 am - 9:30 am: Discussion: Translation from Animals to Humans to Approval